Healthcare provider profile · identity verified

Mary Shapiro, M.D.

Internal Medicine · GLENVIEW, IL · NPI 1457528135

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	542	166
Rosuvastatin Calcium	Rosuvastatin Calcium	403	127
Amlodipine Besylate	Amlodipine Besylate	350	101
Levothyroxine Sodium	Levothyroxine Sodium	319	84
Omeprazole	Omeprazole	267	85
Metoprolol Succinate	Metoprolol Succinate	217	61
Lisinopril	Lisinopril	203	60
Hydrochlorothiazide	Hydrochlorothiazide	149	45
Gabapentin	Gabapentin	140	54
Losartan Potassium	Losartan Potassium	138	42
Simvastatin	Simvastatin	133	34
Valsartan	Valsartan	122	42
Alprazolam	Alprazolam	117	43
Pravastatin Sodium	Pravastatin Sodium	111	36
Alendronate Sodium	Alendronate Sodium	105	29
Metformin Hcl Er	Metformin Hcl	103	30
Sertraline Hcl	Sertraline Hcl	102	31
Ozempic	Semaglutide	100	15
Pantoprazole Sodium	Pantoprazole Sodium	98	37
Carvedilol	Carvedilol	96	31
Ezetimibe	Ezetimibe	94	34
Furosemide	Furosemide	91	39
Montelukast Sodium	Montelukast Sodium	83	28
Synthroid	Levothyroxine Sodium	82	25
Escitalopram Oxalate	Escitalopram Oxalate	78	23
Duloxetine Hcl	Duloxetine Hcl	76	22
Allopurinol	Allopurinol	72	23
Ipratropium Bromide	Ipratropium Bromide	69	23
Bupropion Xl	Bupropion Hcl	68	23
Irbesartan	Irbesartan	67	17
Olmesartan Medoxomil	Olmesartan Medoxomil	61	17
Metformin Hcl	Metformin Hcl	58	20
Meloxicam	Meloxicam	57	17
Metoprolol Tartrate	Metoprolol Tartrate	54	17
Trazodone Hcl	Trazodone Hcl	52	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	15
Spironolactone	Spironolactone	51	21
Zolpidem Tartrate	Zolpidem Tartrate	51	19
Fluoxetine Hcl	Fluoxetine Hcl	48	15
Fluticasone Propionate	Fluticasone Propionate	48	20
Venlafaxine Hcl Er	Venlafaxine Hcl	46	16
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	45	14
Eliquis	Apixaban	43	15
Mounjaro	Tirzepatide	42	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	41	13
Famotidine	Famotidine	40	13
Atenolol	Atenolol	37	suppressed
Celecoxib	Celecoxib	37	15
Tamsulosin Hcl	Tamsulosin Hcl	37	12
Mirtazapine	Mirtazapine	35	15
Diclofenac Sodium	Diclofenac Sodium	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	12
Lorazepam	Lorazepam	32	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	24
Azithromycin	Azithromycin	29	26
Myrbetriq	Mirabegron	29	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	28	21
Tramadol Hcl	Tramadol Hcl	28	13
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	22
Potassium Chloride	Potassium Chloride	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	24	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Clonazepam	Clonazepam	24	14
Lamotrigine	Lamotrigine	24	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	24	24
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Ramipril	Ramipril	22	suppressed
Torsemide	Torsemide	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	19
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Prednisone	Prednisone	21	18
Vitamin D2	Ergocalciferol (Vitamin D2)	21	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	suppressed
Diazepam	Diazepam	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	18	15
Estradiol	Estradiol	18	12
Pregabalin	Pregabalin	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Methylprednisolone	Methylprednisolone	17	17
Temazepam	Temazepam	17	suppressed
Doxepin Hcl	Doxepin Hcl	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Telmisartan	Telmisartan	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	11
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Betamethasone Dipropionate	Betamethasone Dipropionate	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Fluocinolone Acetonide Oil	Fluocinolone Acetonide Oil	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Mupirocin	Mupirocin	14	12
Ondansetron Odt	Ondansetron	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Risperidone	Risperidone	13	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Finasteride	Finasteride	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error